CIRM and UKRMP: Different Ways to Invest in Regenerative Medicine.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27392224.
- Also identified by DOI 10.1016/j.stem.2016.05.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The California Institute for Regenerative Medicine (CIRM) and the UK Regenerative Medicine Platform (UKRMP) have similar objectives, but their histories, funding mechanisms, and governance could hardly be more different. Here, we compare the two programs and explore their impact in translating stem cell research into clinical applications.
Medical subject headings
- Investments
- Regenerative Medicine